Hannah Bye
Impact in
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer Genomics and Diagnostics
-
- Pulmonary Hypertension Research and Treatments
- Advanced Breast Cancer Therapies
Papers in
-
- Epigenetics and DNA Methylation 3
- Cancer-related gene regulation 2
- RNA modifications and cancer 2
-
- Advanced Breast Cancer Therapies 3
- Co-authors
- Matthias Brock (2 shared papers)Natalie J. Prescott (4 shared papers)Christopher G. Mathew (5 shared papers)M. Iqbal Parker (3 shared papers)Marco Matejcic (3 shared papers)Cathryn M. Lewis (3 shared papers)Elizabeth F. Rose (1 shared paper)Christo Van Rensburg (1 shared paper)
- Journals
- Carcinogenesis (3 papers)Journal of Clinical Oncology (3 papers)Cancer Research (3 papers)Inflammatory Bowel Diseases (1 paper)Journal of Molecular Medicine (1 paper)
- Partner nations
- United KingdomSouth AfricaSwitzerland
In The Last Decade
Hannah Bye
15 papers receiving 208 citations
Peers
Comparison fields: 5 of 43
- Cancer Research 57
- Pulmonary and Respiratory Medicine 58
- Pathology and Forensic Medicine 24
- Oncology 32
- Molecular Biology 77
Countries citing papers authored by Hannah Bye
This map shows the geographic impact of Hannah Bye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hannah Bye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hannah Bye more than expected).
Fields of papers citing papers by Hannah Bye
This network shows the impact of papers produced by Hannah Bye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hannah Bye. The network helps show where Hannah Bye may publish in the future.
Co-authors
The 25 scholars most cited alongside Hannah Bye, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 43 | |
| 2 | 2016 | 39 | |
| 3 | 2012 | 37 | |
| 4 | 2015 | 30 | |
| 5 | 2016 | 11 | |
| 6 | 2019 | 9 | |
| 7 | 2018 | 8 | |
| 8 | 2024 | 8 | |
| 9 | 2019 | 7 | |
| 10 | 2019 | 5 | |
| 11 | 2020 | 4 | |
| 12 | 2020 | 3 | |
| 13 | 2017 | 2 | |
| 14 | 2016 | 2 | |
| 15 | The FAS III Development Study Report | 2014 | 1 |
| 16 | 2018 | 0 |
About Hannah Bye
Hannah Bye is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Surgery, Oncology and Cancer Research, having authored 16 papers that have together received 209 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (3 papers), Epigenetics and DNA Methylation (3 papers), Advanced Breast Cancer Therapies (3 papers), Cancer Treatment and Pharmacology (2 papers), Chronic Lymphocytic Leukemia Research (2 papers), Cancer-related gene regulation (2 papers), RNA modifications and cancer (2 papers) and Esophageal Cancer Research and Treatment (2 papers). The work is most often cited by research in Cancer Research (57 citations), Pulmonary and Respiratory Medicine (58 citations), Pathology and Forensic Medicine (24 citations), Oncology (32 citations) and Molecular Biology (77 citations). Hannah Bye has collaborated with scholars based in United Kingdom, South Africa and Switzerland. Frequent co-authors include Matthias Brock, Natalie J. Prescott, Christopher G. Mathew, M. Iqbal Parker, Marco Matejcic, Cathryn M. Lewis, Elizabeth F. Rose, Christo Van Rensburg, Loven Moodley and Barbara Robertson. Their work appears in journals such as Carcinogenesis, Journal of Clinical Oncology, Cancer Research, Inflammatory Bowel Diseases and Journal of Molecular Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.